Clincosm LogoSign in Get a demo

melas

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies Trial in Philadelphia (Promoting Resilience

Recruiting
  • Mitochondrial Diseases
  • +4 more
  • Promoting Resilience in Stress Management (PRISM)
  • Clinical-focused narrative (CFN)
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Sep 12, 2023

MELAS Trial in United States (IW-6463 Tablets)

Completed
  • MELAS
  • IW-6463 Tablets
  • Washington, District of Columbia
  • +4 more
Jun 13, 2022

Tissue Sample Study for Mitochondrial Disorders

Enrolling by invitation
  • Mitochondrial Disorders
  • +8 more
    • New York, New York
      Columbia University
    Apr 4, 2022

    Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation, MELAS Trial in Nijmegen (Sonlicromanol, Placebo)

    Recruiting
    • Mitochondrial Diseases
    • +3 more
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Jan 26, 2022

    MELAS, LHON, Leigh Syndrome Trial in Ghent (KH176, )

    Completed
    Has Results
    • MELAS
    • +4 more
    • Ghent, Belgium
      Drug Research Unit Ghent
    Oct 15, 2021

    Mitochondrial Diseases, Mitochondrial Myopathies, Progressive External Ophthalmoplegia Trial in Cambridge (Nicotinamide

    Unknown status
    • Mitochondrial Diseases
    • +8 more
    • Nicotinamide Riboside
    • Cambridge, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jul 4, 2019

    Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies Trial in Nijmegen (KH176, )

    Completed
    • Mitochondrial Diseases
    • +4 more
    • Nijmegen, Netherlands
      Radboud University Medical Center
    Feb 22, 2018